Yahoo Web Search

Search results

    • Q1 2024 BioXcel Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      Our TRANQUILITY In-Care trial is designed as a double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of a 60 microgram dose of 501 over a ...

    • Q2 2024 RMR Group Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 days ago

      First quarter financial results reflect continued improvement in DHC.'s shop segment with same property cash basis NOI increasing almost 10% year over year and continued roll-up of roll-ups ...

    • Editorial Roundup: New England

      US News & World Report· 18 hours ago

      By vetoing a ban on bump stocks and opting not to support the 72-hour waiting period, the governor let Mainers down. Gov. Janet Mills’ veto of a bill that would have banned bump stocks, the ...